Literature DB >> 20731866

Treatment of refractory hip pain with sodium hyaluronate (Hyalgan(c)) in a patient with the Marshall-Smith Syndrome: A case report.

Matthew Salter1, Chandoo Kalmat, Henry Kroll, David Kim.   

Abstract

The Marshall Smith Syndrome (MSS) is a rare congenital disorder, displaying a constellation of unique symptoms, including orofacial dysmorphisms, accelerated osseous maturation and dysplasias, mental retardation, and respiratory maladies. Few individuals with MSS survive past early childhood. In this case report, we describe a unique treatment for a 30 year-old patient with MSS who presented to our pain medicine clinic for management of pain secondary to uncontrolled bilateral hip dysplasias.

Entities:  

Year:  2010        PMID: 20731866      PMCID: PMC2933713          DOI: 10.1186/1749-799X-5-61

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  26 in total

Review 1.  Marshall-Smith syndrome: case report of a newborn male and review of the literature.

Authors:  D A Summers; H A Cooper; M G Butler
Journal:  Clin Dysmorphol       Date:  1999-07       Impact factor: 0.816

2.  Osseous fragility in Marshall-Smith syndrome.

Authors:  Mohammad Diab; Michael Raff; Daniel F Gunther
Journal:  Am J Med Genet A       Date:  2003-06-01       Impact factor: 2.802

Review 3.  Marshall-Smith syndrome: natural history and evidence of an osteochondrodysplasia with connective tissue abnormalities.

Authors:  Margaret P Adam; Raoul C M Hennekam; Laura Davis Keppen; Marilyn J Bull; Carol L Clericuzio; Leah W Burke; Kelly E Ormond; Eugene H Hoyme
Journal:  Am J Med Genet A       Date:  2005-08-30       Impact factor: 2.802

4.  The Marshall-Smith syndrome: a review of the laryngeal complications.

Authors:  A Cullen; T A Clarke; T P O'Dwyer
Journal:  Eur J Pediatr       Date:  1997-06       Impact factor: 3.183

5.  Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study.

Authors:  Robert S Salk; Thomas J Chang; Walter F D'Costa; David J Soomekh; Kirk A Grogan
Journal:  J Bone Joint Surg Am       Date:  2006-02       Impact factor: 5.284

6.  Hyaluronic acid attenuates osteoarthritis development in the anterior cruciate ligament-transected knee: Association with excitatory amino acid release in the joint dialysate.

Authors:  Yen-Hsuan Jean; Zhi-Hong Wen; Yi-Chen Chang; Herng-Sheng Lee; Shih-Peng Hsieh; Ching-Tang Wu; Chun-Chang Yeh; Chih-Shung Wong
Journal:  J Orthop Res       Date:  2006-05       Impact factor: 3.494

Review 7.  What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.

Authors:  Michel P J van den Bekerom; Bas Lamme; An Sermon; Michiel Mulier
Journal:  Arch Orthop Trauma Surg       Date:  2007-09-15       Impact factor: 3.067

8.  Effect of intraarticular hyaluronan injection in experimental canine osteoarthritis.

Authors:  G N Smith; S L Myers; K D Brandt; E A Mickler
Journal:  Arthritis Rheum       Date:  1998-06

9.  Viscosupplementation: a new concept in the treatment of sacroiliac joint syndrome: a preliminary report of four cases.

Authors:  U Srejic; O Calvillo; K Kabakibou
Journal:  Reg Anesth Pain Med       Date:  1999 Jan-Feb       Impact factor: 6.288

10.  Marshall-Smith syndrome: new radiographic, clinical, and pathologic observations.

Authors:  G F Eich; M M Silver; R Weksberg; A Daneman; T Costa
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.